FDA Clearance Tracker · K182960
ReliefBand
Last checked: Nov 20, 2026Latest source record: Jun 21, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Jun 21, 2019
Substantially Equivalent
Time to decision
239 days
Received Oct 25, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K182960
- Device name
- ReliefBand
- Applicant
- Reliefband Technologies, LLC
- Applicant location
- Horsham, PA
- Received
- Oct 25, 2018
- Decided
- Jun 21, 2019
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5890
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GZJ. The earliest in FDA's data is K761053, decided Nov 30, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K182960
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Reliefband Technologies, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- ReliefBand510(k)
K191547 · Decided Aug 30, 2019 · 79 days after receipt
Device type: Stimulator, Nerve, Transcutaneous, For Pain Relief (GZJ) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.